Millions of patients worldwide have been treated therapeutically with BOTOX® over the course of nearly 20 years.And Allergan is honoring its commitment to these patients through the provision of quality product, patient and physician education, and the continued pursuit of novel neurotoxin-based therapeutics.
In the United States, BOTOX® is currently being investigated for the treatment of other medical conditions.
BOTOX® is a purified protein that works by blocking overactive nerve impulses that trigger excessive muscle contractions or glandular activity. The effect is temporary and lasts from approximately one to six months, depending on the individual patient and indication. BOTOX® therapy should only be administered by a trained and qualified physician. Approved therapeutic indications for BOTOX® in the United States include the following: Blepharospasm, Cervical dystonia, Chronic Migraine etc.